TY  - CONF 
AU  - AGRASO BUSTO, SARA
AU  - VARELA POSE, VANESA
AU  - Fernández Nuñez, Natalia
AU  - Firvida  Perez, Jose Luis
AU  - Santome, L.
AU  - Afonso Afonso, Francisco Javier
AU  - Azpitarte Raposeiras, Cristina
AU  - DE DIOS ALVAREZ, NOEMI
AU  - Garcia, J.
AU  - Campos Balea, Begoña
AU  - Areses Manrique, María Carmen
AU  - PEREIRO CORBACHO, DIEGO
AU  - Lazaro Quintela, Martín
PY  - 2019
SN  - 1556-0864
UR  - http://hdl.handle.net/20.500.11940/15806
AB  - Background
Treatment with tyrosine kinasa inhibitors has been a revolution for the patients with non-small cell lung cancer and EGFR positive mutation, especially in patients with exon 19 deletions. Afatinib seems one of the best options of...
LA  - eng
TI  - EPI.14-15 Real World Clinical Experience of the Galician Lung Cancer Group: Afatinib in Patients with EGFR Positive Mutation
DO  - 10.1016/j.jtho.2019.08.2300
KW  - CHUVI
KW  - CHUF
KW  - CHUO
KW  - HULA
KW  - CHUP
VL  - 14
ER  -